A new study on essential oils for sore throat: what it tested and what it does not say

If you have ever sat in a primary care office with a raw throat and walked out with a 10-day antibiotic script, you are in good company. Sore throat (acute pharyngotonsillitis) is one of the most common reasons adults visit primary care, and antibiotics are still prescribed in most of those visits, even though guidelines have said for years that the majority of cases are viral. A new study out of Spain looked at whether a five-day course of an oral essential oil capsule could give comparable symptom relief to penicillin V, while letting most patients skip antibiotics altogether. The result is interesting, but it needs careful reading.

Image by Leon_Ting via Pixabay

What the research found

This was a retrospective observational study run by seven general practitioners in Spain during the 2023–2024 respiratory infection season [1]. Ninety-seven adults with clinically diagnosed mild-to-moderate acute pharyngotonsillitis were treated in one of three ways. Group A received oral Penicillin V (500 mg twice daily for 10 days). Group B received a standardized oral essential oil formulation (Oleobiotic Salud Respiratoria, 1 capsule three times daily for 5 days) containing oregano, eucalyptus, cinnamon, Scots pine, and lemon peel oils. Group C received the same essential oil product at double the dose (2 capsules three times daily for 5 days). Patients tracked their sore throat severity on a visual analog scale, their overall health perception, body temperature, and adverse events daily for 10 days via WhatsApp, SMS, or email.

All three groups improved significantly over time on the sore throat score (P < 0.001 at days 3, 5, and 10). By day three, 100 percent of the antibiotic group, 88 percent of the standard-dose essential oil group, and 91 percent of the double-dose essential oil group reported improvement in sore throat severity. Overall health perception improved similarly in all three arms. Adverse events were mild and gastrointestinal (dyspepsia, nausea, reflux, mild diarrhea) in 10 patients total across all groups. Eighty-nine percent of patients who used the essential oil therapy said they would use it again. The treating physicians estimated that the essential oil therapy let them avoid an antibiotic prescription in 85 to 88 percent of cases that received it.

Three caveats from the trial itself. It was open-label, with no placebo arm. It had no microbiological confirmation of which patients had bacterial versus viral infection. And it had no biomarkers. The patients were also adults with mild-to-moderate symptoms in primary care, not severe presentations.

The bigger picture

Two points from the broader literature help frame this. First, the etiology piece. A 2025 ten-year hospital surveillance study from Taiwan found that of 117 adults hospitalized with acute pharyngotonsillitis, only one had Group A Streptococcus on workup. Forty-two had herpes simplex virus, twenty-six had adenovirus, sixteen had acute HIV, twelve had influenza, and the rest were other viruses. Yet 89 percent received antibiotics in the emergency department [2]. Most adult sore throats are not bacterial, and the dominant pathogen pattern is viral, which means the antibiotic is doing nothing useful for most patients who receive one.

Second, the stewardship piece. A 2024 Croatian study of an academic detailing intervention in primary care showed that targeted physician education cut antibiotic prescribing for acute pharyngitis by 30 percent and for acute tonsillitis by 33 percent, without obvious clinical fallout [3]. The current standard of care for distinguishing bacterial from viral pharyngitis still relies on the Modified Centor (or McIsaac) criteria, plus rapid antigen or NAAT testing when available, with emerging interest in inflammatory biomarkers to improve specificity [4]. Even with those tools, overprescribing remains the norm in many primary care settings.

That is the gap this essential oil study tries to address. It does not prove the formulation cures or treats anything. It suggests that for adults with mild symptoms who would otherwise have walked out with a penicillin script they did not need, a structured botanical option may be acceptable to patients and may not delay clinical improvement.

The naturopathic lens

Most viral sore throats are self-limited illnesses that resolve with rest, hydration, and supportive care. The body knows how to clear them. The interesting question is not "what kills the pathogen fastest" but "what supports the host while the pathogen runs its course, and what reduces the small portion of cases where bacterial infection or complications need a different response."

Essential oils have measurable antimicrobial and anti-inflammatory effects in lab studies, including against respiratory pathogens. Whether that translates into the human throat in any clinically meaningful way, beyond the symptom relief that any soothing herbal preparation might offer, is the open question. The Spanish study did not answer that. It is consistent with a long tradition of using aromatic, warming, antimicrobial plants for sore throat, while also being limited by all the methodologic gaps the authors named.

In my own clinical work with patients managing upper respiratory infections, the questions I think through with people are not which one product to use. They are: How sick are you, and is escalation warranted? Are there red flags (high fever, tonsillar exudates, tender anterior cervical nodes, recent strep exposure, immune compromise) that change the calculus? What does your immune picture look like (sleep, stress, nutrient status, gut function, history of recurrent infections)? And what supportive care will help you ride this out (rest, hydration, warm liquids, demulcent herbs like marshmallow root or slippery elm, salt-water gargles, throat-coating teas, and yes, well-chosen botanicals for their mild antimicrobial and anti-inflammatory profile)?

Botanical antimicrobials sit alongside, not in place of, that whole-person assessment. A new study like this one is best read as one more piece of evidence that there is a defensible space for botanical therapeutics in mild upper respiratory illness, while a sober look at the design also says we are not yet at the point where any clinician should be recommending a specific commercial capsule as a standard antibiotic alternative.

How to apply this in your own life

A few practical reads if you get a sore throat and want to be a thoughtful participant in your own care:

1. Most adult sore throats are viral. Antibiotics will not shorten a viral illness and carry their own costs to the microbiome and to antimicrobial resistance more broadly.

2. Know the red flags that warrant a clinical evaluation: high fever, severe difficulty swallowing, drooling, neck swelling, rash, breathing trouble, or symptoms that worsen instead of resolve over several days.

3. Standard supportive care (rest, fluids, warm liquids, salt-water gargles, demulcent teas, throat lozenges, humidification) does most of the work in uncomplicated cases.

4. Botanical antimicrobials, including oregano-based formulations, have a small but growing evidence base for upper respiratory symptom support. They are not the same as a clinical decision to skip antibiotics. That call belongs with your clinician, ideally one who applies a tool like the Modified Centor criteria and uses rapid testing when indicated.

5. If you find yourself getting recurrent sore throats, look upstream. Sleep, stress load, nutrient status, gut function, and recovery from prior viral illness all influence how often the next one shows up.

References

1. Today's Practitioner. Real-World Outcomes Using Oral Essential Oils for Acute Pharyngotonsillitis. Published 2026-03-11; updated 2026-06-17. URL: https://todayspractitioner.com/botanical-medicine/oral-essential-oil-therapy-for-acute-pharyngotonsillitis-study/. Primary source coverage of a 97-patient observational study by seven Spanish primary care physicians, published in Otorhinolaryngology (study PDF: https://todayspractitioner.com/wp-content/uploads/2026/03/OTORHINOLARYNGOLOGY.pdf).

2. Liang CW, Hsiao MC, Kuo SH, et al. Do Hospitalized Adult Patients with Acute Pharyngotonsillitis Need Empiric Antibiotics? The Impact on Antimicrobial Stewardship. Microorganisms. 2025;13(3):628. PMID: 40142520. DOI: 10.3390/microorganisms13030628.

3. Kuruc Poje D, Kifer D, Kuharić M, et al. Evaluating academic detailing as an antibiotic stewardship intervention in primary healthcare settings in Croatia. BMC Prim Care. 2024;25(1):426. PMID: 39702020. DOI: 10.1186/s12875-024-02679-9.

4. Ledeboer NA, Caldwell JM, Boyanton BL. Review: Diagnostic Potential for Collaborative Pharyngitis Biomarkers. J Infect Dis. 2024;230(Suppl 3):S190-S196. PMID: 39441193. DOI: 10.1093/infdis/jiae416.

This information is educational and is not medical advice. Symptoms of strep throat, severe sore throat, difficulty breathing, or symptoms that do not improve warrant evaluation by a qualified healthcare provider. Decisions about whether to use a specific botanical product, including any oral essential oil formulation, should be made with a clinician who knows your history.

---

If this resonates with what you're experiencing and you'd like to explore a naturopathic approach, book a consultation with our clinic.